Divozilimab

Tax included
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research.
MedChemExpress 
HY-P99855

Data sheet

Size
Multiple sizes
Reactivity
CD20
Application
COVID-19-immunoregulation
CAS
2254061-60-2